Fig. 2: METTL3 and YTHDF1 indicate the poor prognosis of CC patients.

a RT-PCR indicated the METTL3 mRNA in the CC tissue samples and normal control. b RT-PCR indicated the YTHDF1 level in the CC tissue and normal samples. c Prognosis analysis indicated the survival rate of CC patients with high or low METTL3 level. d Survival of CC patients with high or low YTHDF1 in collected CC cohort. Data are displayed as mean ± standard deviation. **p < 0.01 vs. control. *p < 0.05 vs. control.